Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

The US Environmental Protection Agency (EPA) disclosed Monday that it banned nearly all uses of trichloroethylene (TCE) — an ...

AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 4, 2024 — A ...

Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...

Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...

A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...

Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about what causes Parkinson’s disease and what can be done to reduce the ...

Managing patients with Parkinson's disease should be viewed as part of a hospital CMO's responsibility for patient safety and quality, says this healthcare leader. These risks are medication ...